Concept information
Preferred term
Ondansetron
Type
-
mesh:Descriptor
Definition
- A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Broader concept
Entry terms
- 110707-92-1 (HCl)
- 4AF302ESOS
- 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-
- 99614-01-4 (mono-HCl)
- 99614-02-5 (Ondansetron)
- 99614-58-1 ((S)-isomer)
- 99614-60-5 ((R)-isomer)
- NMH84OZK2B
- Ondansetron, (+,-)-Isomer
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
110707-92-1 (HCl)
-
4AF302ESOS
-
99614-01-4 (mono-HCl)
-
99614-02-5 (Ondansetron)
-
99614-58-1 ((S)-isomer)
-
99614-60-5 ((R)-isomer)
-
NMH84OZK2B
URI
http://data.loterre.fr/ark:/67375/JVR-KTJSF06G-B
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}